Results 111 to 120 of about 415 (149)

[Chinese guideline for diagnosis and treatment of hairy cell leukemia (2023)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Hematology Oncology Committee   +4 more
europepmc   +1 more source

丙型肝炎病毒核心抗原在HBV/HCV合并感染者血清中的检测状况及影响因素分析

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2011
【目的】 探讨丙型肝炎病毒核心抗原(HCVcAg)在乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)合并感染者血清中的检出状况,并分析其影响因素【方法】检测88例慢性丙型肝炎和62例HBV/HCV合并感染患者血清HCVcAg和HCV RNA,对后者血清进行HBV DNAHBeAg检测,分析HCVcAg检出率与HBeAgHBV DNA定量检测关系【结果】 88例慢性丙型肝炎和62例HBV/HCV合并感染者血清HCVcAg的检出率分别是72.7%(64/88)和38.7%(24/62),χ= 17.358,P
doaj  

[The Chinese clinical expert consensus for the BCMA bispecific T cell engager in the treatment of multiple myeloma (2025)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Chinese Hematology Association   +6 more
europepmc   +1 more source

Comparison of tenofovir alafenamide and entecavir for hepatitis B virus-related acute-on-chronic liver failure. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban, 2022
Peng W   +5 more
europepmc   +1 more source

[HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Tang S   +5 more
europepmc   +1 more source

[Avatrombopag combined with standard immunosuppressive therapy in the treatment of severe aplastic anemia with hepatic impairment in six patients]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2022
Li JP   +12 more
europepmc   +1 more source

[Daratumumab maintenance after autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Ma Y   +12 more
europepmc   +1 more source

小剂量泼尼松联合恩替卡韦治疗以大量蛋白尿表现的乙肝病毒相关性肾炎3例 附视频

open access: yesLinchuang shenzangbing zazhi
乙肝病毒相关性肾炎(hepatitisBvirus-associated glomerular nephritis,HBV-GN)是指由乙型肝炎病毒(hepatitis B virus,HBV)直接或间接诱发的肾小球肾炎,中国是乙型肝炎的高发国家。据数据统计,中国成年人HBV携带率高达10%以上,其中HBV-GN的发生率约为9.0%[1]。针对HBV-GN目前临床尚无特效疗法,单纯核苷酸类似物治疗大量蛋白尿HBV-GN的尿蛋白缓解率低[2],临床疗效并不理想。目前通过糖皮质激素 ...
doaj  

输血及血液制品与慢性HBV感染患者发生HCV重叠感染的关系

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1995
通过检测丙型肝炎抗体与丙型肝炎病毒(HCV)核糖核酸的方法对广东地区442例慢性乙型肝炎病毒(HBV)感染者发生HCV重叠感染的状况进行流行病学调查,分析其与输血及血制品的关系。结果显示慢性HBV感染患者中HCV重叠感染率为9.73%;其发生主要与治疗性输用血浆有关。与不输血制品相比,输白蛋白、输血浆和输血浆加白蛋白引起HCV重叠感染的相对危险度分别为2.13,122.57和125.84。而且血浆输入量越大,发生重叠感染的危险性也越大。当输注血浆超过16次,重叠感染率可达77.78%
doaj  

Home - About - Disclaimer - Privacy